HAVCR2 and cancer: TIM‐3 (p = 0.003), LAG‐3 (p = 0.007) and PD‐1 (p = 0.002) stromal immune cell expression, as well as tumoural PD‐1 (p = 0.049) and CICSS (p < 0.001) were significantly associated with cancer‐specific survival.